Jiangsu Yahong Meditech Co. Ltd.
Jiangsu Yahong Meditech Co., Ltd., a pharmaceutical company, focuses on urogenital tumors and women's health in China and internationally. It develops APL-1702, a photodynamic therapy product for the treatment of high-grade squamous intraepithelial lesions of the cervix, as well as for HPV virus clearance indication; APL-1706 and APLD-2304 for non-muscle invasive bladder cancer (NMIBC) diagnosis … Read more
Jiangsu Yahong Meditech Co. Ltd. (688176) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.062x
Based on the latest financial reports, Jiangsu Yahong Meditech Co. Ltd. (688176) has a cash flow conversion efficiency ratio of -0.062x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-107.53 Million) by net assets (CN¥1.74 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jiangsu Yahong Meditech Co. Ltd. - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Jiangsu Yahong Meditech Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Jiangsu Yahong Meditech Co. Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Yahong Meditech Co. Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PTT OIL+RET.BUS.-FOR-BA10
F:7F8
|
N/A |
|
Arctech Solar Holding Co Ltd
SHG:688408
|
0.068x |
|
TVS Holdings Limited
NSE:TVSHLTD
|
-0.376x |
|
Guizhou Bailing Group Pharmaceutical Co Ltd
SHE:002424
|
0.090x |
|
SeaWorld Entertainment Inc
F:W2L
|
-0.307x |
|
Purecycle Technologies Holdings Corp
NASDAQ:PCT
|
-0.564x |
|
Yibin Tianyuan Group Co Ltd
SHE:002386
|
0.021x |
|
Omeros Corporation
NASDAQ:OMER
|
0.084x |
Annual Cash Flow Conversion Efficiency for Jiangsu Yahong Meditech Co. Ltd. (2018–2024)
The table below shows the annual cash flow conversion efficiency of Jiangsu Yahong Meditech Co. Ltd. from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.97 Billion | CN¥-424.95 Million | -0.216x | -29.44% |
| 2023-12-31 | CN¥2.39 Billion | CN¥-398.19 Million | -0.167x | -90.82% |
| 2022-12-31 | CN¥2.77 Billion | CN¥-241.96 Million | -0.087x | -53.38% |
| 2021-12-31 | CN¥3.01 Billion | CN¥-171.52 Million | -0.057x | +63.55% |
| 2020-12-31 | CN¥806.50 Million | CN¥-125.95 Million | -0.156x | +94.94% |
| 2019-12-31 | CN¥28.75 Million | CN¥-88.83 Million | -3.089x | -176.07% |
| 2018-12-31 | CN¥47.21 Million | CN¥-52.83 Million | -1.119x | -- |